Related Experiment Video
Updated: May 22, 2026

Sampling Cerebrospinal Fluid and Blood from Lateral Tail Vein in Rats During EEG Recordings
Published on: September 1, 2023
[CSF biomarkers in children with acute encephalopathy syndrome]
1Department of Pediatrics, Tokyo Metropolitan Fuchu Medical Center for the Disabled.
Insights
Viral infection-associated acute encephalopathy, a severe condition in children, presents with impaired consciousness and seizures. Tau protein and 8-hydroxy-2'deoxyguanosine (8-OHdG) show potential as biomarkers for early diagnosis and treatment monitoring.
Area of Science:
- Pediatric Neurology
- Infectious Diseases
- Biomarker Discovery
Context:
- Acute encephalopathy in children, often triggered by viral infections, carries significant mortality and neurological risks.
- Key symptoms include impaired consciousness, status epilepticus, and hyperpyrexia.
- Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is a specific subtype with characteristic biphasic seizures and MRI findings.
Purpose:
- To identify potential biomarkers for the early diagnosis and management of viral infection-associated acute encephalopathy.
- To differentiate AESD from febrile seizures in the early clinical phase.
- To explore the utility of tau protein and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in monitoring disease progression and therapeutic response.
Summary:
- Viral infection-associated acute encephalopathy is a critical pediatric neurological syndrome.
- AESD presents with biphasic seizures and specific MRI abnormalities, posing diagnostic challenges.
- Tau protein and 8-OHdG are proposed as promising biomarkers for early detection and treatment monitoring.
Impact:
- Early diagnosis of AESD can lead to timely intervention, potentially mitigating severe neurological impairment.
- Identifying reliable biomarkers like tau protein and 8-OHdG could revolutionize the management of acute encephalopathy.
- Improved monitoring of treatment efficacy through biomarkers may enhance patient outcomes and reduce long-term sequelae.
Abstract:
Viral infection-associated acute encephalopathy in children is a clinical syndrome with high mortality and neurological sequelae. Its main symptoms of acute phase are impaired consciousness and convulsive status epilepticus with hyperpyrexia. Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is characterized clinically by biphasic seizures and late MRI abnormalities such as reduced subcortical diffusion. Despite the intensive care, patients with AESD often have severe neurological impairment and it is very difficult to distinguish AESD from febrile seizures in the early phase. Although there is currently no specific biomarker for early diagnosis of acute encephalopathy syndrome, we believe tau protein and 8-hydroxy-2'-deoxyguanosine (8-OHdG) are potential biomarkers which could be useful in following the clinical course and monitoring the efficacy of therapies.
More Related Videos
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
07:01A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
Published on: February 7, 2025
Related Concept Videos
Viral Meningitis
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction
Hepatic Encephalopathy